Triiodo-substituted derivatives of BENZOIC ACID.
The imide of phthalic acids.
Acetic acid derivatives of the heterocyclic compound indole. (Merck Index, 11th ed)

Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. (1/214)

BACKGROUND: Intravascular radiocontrast agents may cause acute renal failure, particularly in patients with pre-existing renal insufficiency. Direct cytotoxic effects of radiocontrast agents on renal tubular cells may contribute to the pathogenesis of radiocontrast-induced nephropathy. METHODS: We analysed the cytotoxicity of the ionic radiocontrast agents diatrizoate (monomeric) and ioxaglate (dimeric), as well as of the non-ionic radiocontrast agents iohexol (monomeric) and iodixanol (dimeric) on the renal epithelial Madin Darby Canine Kidney (MDCK) cell line grown on permeable supports. The toxicity assays assessed cell viability, transmonolayer resistance and inulin permeability between the apical and basal cell culture compartment. In addition, the distribution of the tight-junction-associated membrane proteins ZO-1 and occludin was analysed using immunofluorescence microscopy. RESULTS: In all assays the high osmolal ionic compound diatrizoate had significant cytotoxic effects that included the partial redistribution of the tight-junction-associated membrane proteins into a cytoplasmic compartment. To a lesser extent this redistribution also occurred with the dimeric ionic compound ioxaglate, but not with the non-ionic radiocontrast agents. With regards to cell viability, transmonolayer resistance and inulin permeability the radiocontrast agents with reduced osmolality were significantly less toxic than diatrizoate, independent of their ionic strength. CONCLUSIONS: Physicochemical factors contribute to the cytotoxicity of radiocontrast agents in vitro. The redistribution of tight-junction-associated membrane proteins by the ionic radiocontrast agents corresponds with the loss of the barrier function of the epithelial cell monolayer, which is a major pathophysiological mechanism in acute renal failure. The radiocontrast agents with reduced osmolality are less cytotoxic than diatrizoate, independent of their ionicity. Hyperosmolality appears to be a more important determinant of the cytotoxicity of diatrizoate than ionic strength.  (+info)

Responses of plant vascular systems to auxin transport inhibition. (2/214)

To assess the role of auxin flows in plant vascular patterning, the development of vascular systems under conditions of inhibited auxin transport was analyzed. In Arabidopsis, nearly identical responses evoked by three auxin transport inhibitor substances revealed an enormous plasticity of the vascular pattern and suggest an involvement of auxin flows in determining the sites of vascular differentiation and in promoting vascular tissue continuity. Organs formed under conditions of reduced auxin transport contained increased numbers of vascular strands and cells within those strands were improperly aligned. In leaves, vascular tissues became progressively confined towards the leaf margin as the concentration of auxin transport inhibitor was increased, suggesting that the leaf vascular system depends on inductive signals from the margin of the leaf. Staged application of auxin transport inhibitor demonstrated that primary, secondary and tertiary veins became unresponsive to further modulations of auxin transport at successive stages of early leaf development. Correlation of these stages to anatomical features in early leaf primordia indicated that the pattern of primary and secondary strands becomes fixed at the onset of lamina expansion. Similar alterations in the leaf vascular responses of alyssum, snapdragon and tobacco plants suggest common functions of auxin flows in vascular patterning in dicots, while two types of vascular pattern alterations in Arabidopsis auxin transport mutants suggest that at least two distinct primary defects can result in impaired auxin flow. We discuss these observations with regard to the relative contributions of auxin transport, auxin sensitivity and the cellular organisation of the developing organ on the vascular pattern.  (+info)

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. (3/214)

Conventional methods for rAAV purification that are based on cesium chloride ultracentrifugation have often produced vector preparations of variable quality and resulted in significant loss of particle infectivity. We report here several novel purification strategies that involve the use of non-ionic iodixanol gradients followed by ion exchange or heparin affinity chromatography by either conventional or HPLC columns. These methods result in more than 50% recovery of rAAV from a crude lysate and routinely produce vector that is more than 99% pure. More importantly, the new purification procedures consistently produce rAAV stocks with particle-to-infectivity ratios of less than 100, which is significantly better than conventional methods. The new protocol increases the overall yield of infectious rAAV by at least 10-fold and allows for the complete purification of rAAV in 1 working day. Several of these methods should also be useful for large-scale production.  (+info)

Biotransformation of nonionic X-Ray contrast agents In vivo and In vitro. (4/214)

Liposomes loaded with the nonionic iodinated contrast agent iodixanol were injected i.v. into monkeys, rats, and dogs, and liver samples were analyzed by HPLC and mass spectrometry. Two metabolites (M1 and M2), with UV spectra identical to those of the iodixanol isomers (exo and endo) and with a mass increase of 162 compared with iodixanol, were detected. Incubations of iodixanol-liposomes or iodixanol in rat liver homogenates resulted in large amounts of iodixanol metabolites, whereas no metabolites were formed in other organ or tissue homogenates. Four groups of unidentified HPLC peaks were detected: M1 and M2 with a relative retention similar to the metabolite peaks of the in vivo samples, and in addition the minor M3 and M4. UV spectrum analysis indicated that M1 and M3 were structurally related to the iodixanol exo-isomer, whereas M2 and M4 were related to the endo-isomer. Mass spectrometry techniques indicated that the metabolites were conjugates containing one or two hexose residues, which by carbohydrate analysis and experiments with concanavalin A-Sepharose and alpha- and beta-glucosidase were shown to be glucose residues bound to iodixanol through O-alpha1-glycoside-like linkages. Metabolites with similar mass increments also were detected for several other nonionic contrast agents after in vitro incubations in liver homogenates. In conclusion, M1 and M3 are conjugates of the iodixanol exo-isomer with one and two glucose adducts, respectively. M2 and M4 are similar conjugates of the iodixanol endo-isomer. This is the first report on hepatic biotransformation of this class of X-ray contrast agents.  (+info)

Purification and protein composition of PM2, the first lipid-containing bacterial virus to be isolated. (5/214)

The marine, icosahedral bacteriophage PM2 was isolated in the late 1960s. It was the first phage for which lipids were firmly demonstrated to be part of the virion structure and it has been classified as the type organism of the Corticoviridae family. The host, Pseudoalteromonas espejiana BAL-31, belongs to a common group of marine bacteria. We developed a purification method producing virions with specific infectivity approximately as high as that of the lipid-containing phages PRD1 and φ6. The sensitivity of the virus to normally used purification media such as those containing sucrose is demonstrated. We also present an alternative host, a pseudoalteromonad, that allows enhanced purification of the virus under reduced salt conditions. We show, using N-terminal amino acid sequencing and comparison with the genomic sequence, that there are at least eight structural proteins in the infectious virus.  (+info)

Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. (6/214)

1 We have used isolated arterial preparations from the rabbit and dog to investigate whether non-ionic iodinated radiographic contrast media (IRCM) modulate nitric oxide (NO) release. The tri-iodinated monomers iopromide and iohexol were compared with the hexa-iodinated dimer iodixanol. 2 The vasodilator effects of iohexol (300 mg ml-1) and iodixanol (320 mg ml-1) were assessed in cascade bioassay. Increasing concentrations of iohexol or iodixanol caused concentration-dependent relaxations of the detector tissue which were insensitive to 100 microM NG-nitro L-arginine methyl ester (L-NAME) and 10 microM indomethacin, whereas viscosity-associated relaxations induced by the 'inert' agent dextran (MW 80,000; 1-4%) were attenuated by inhibition of NO synthesis. 3 Relaxations of endothelium-intact rings to acetylcholine (ACh) were attenuated by preincubation with iohexol or iodixanol, whereas relaxations to sodium nitroprusside (SNP) in endothelium-denuded rings were unaffected. Inhibitory activity did not correlate with either molarity or iodine concentration. Mannitol caused inhibition of both ACh- and SNP-induced responses. 4 In isolated perfused arteries the depressor responses to iodixanol (320 mg ml-1) and iopromide (300 mg ml-1) administered as close arterial bolus attained a plateau with maximal dilatations of approximately 25% and approximately 60%, respectively. Addition of 100 microM NG-nitro L-arginine (L-NOARG) and/or 10 microM indomethacin to the perfusate had no effect on the responses to either agent. 5 We conclude that IRCM exert direct effects on the endothelium that inhibit NO production rather than its action on vascular smooth muscle. Shear stress-induced stimulation of NO production by IRCM is unlikely to contribute to their vasodilator activity in vivo when administered during angiography despite high intrinsic viscosity.  (+info)

Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats. (7/214)

We report on the development of a method for repeated monitoring of mucosal permeability that allows assessment of the severity of colitis and evaluation of treatment efficacy in HLA-B27 transgenic rats. We determined the extent to which intestinal permeability related to stool condition, colon weight, and histological pathology in precolitic and diseased rats up to 29 weeks old. Intestinal permeability was measured by the urinary excretion of iodixanol at 24 h after oral administration. Mean permeability values increased significantly with age in HLA-B27 rats but remained decreased in the background strain Fischer-344 (F-344) control animals. Macroscopic evaluation of HLA-B27 rat colons between 20 and 24 weeks old showed colonic thickening with colonic wet weights increased from 3.4+/-0.13 mg/kg b.wt. in F-344 rats to 6.79+/-0.73 mg/kg b.wt. (p<.05) in HLA-B27 rats. Histological examination of HLA-B27 rat colons confirmed the colonic inflammation as a chronic active mononuclear cell infiltrate. The increase in colon weight was associated with an increase in permeability: 1.16+/-0.17 mg iodixanol versus 5.37+/-1.3 mg of iodixanol in F-344 and HLA-B27 rats, respectively. Three weeks treatment of HLA-B27 rats with cyclosporin A, but not sulfasalazine, showed a dose-dependent decrease in mucosal permeability and colon weight. Neither treatment improved stool condition. We conclude that the measurement of intestinal permeability by iodixanol excretion is a useful biochemical marker that is associated with increases in colonic weight and histological evaluation of inflammation. These data indicate that this technique may be valuable for diagnostic and evaluation purposes in preclinical models of inflammatory bowel disease.  (+info)

Auxin is required for leaf vein pattern in Arabidopsis. (8/214)

To investigate possible roles of polar auxin transport in vein patterning, cotyledon and leaf vein patterns were compared for plants grown in medium containing polar auxin transport inhibitors (N-1-naphthylphthalamic acid, 9-hydroxyfluorene-9-carboxylic acid, and 2,3,5-triiodobenzoic acid) and in medium containing a less well-characterized inhibitor of auxin-mediated processes, 2-(p-chlorophynoxy)-2-methylpropionic acid. Cotyledon vein pattern was not affected by any inhibitor treatments, although vein morphology was altered. In contrast, leaf vein pattern was affected by inhibitor treatments. Growth in polar auxin transport inhibitors resulted in leaves that lacked vascular continuity through the petiole and had broad, loosely organized midveins, an increased number of secondary veins, and a dense band of misshapen tracheary elements adjacent to the leaf margin. Analysis of leaf vein pattern developmental time courses suggested that the primary vein did not develop in polar auxin transport inhibitor-grown plants, and that the broad midvein observed in these seedlings resulted from the coalescence of proximal regions of secondary veins. Possible models for leaf vein patterning that could account for these observations are discussed.  (+info)

Triiodobenzoic acids are a group of organic compounds that contain a benzene ring substituted with three iodine atoms and a carboxyl group. They have the general formula C6H3I3CO2H. These compounds do not have a specific medical definition, but they may be used in medical or pharmaceutical applications due to their chemical properties. For instance, some triiodobenzoic acids can act as radioactive tracers in medical imaging or as precursors in the synthesis of certain drugs. However, direct exposure to these compounds should be avoided as they can be harmful if swallowed, inhaled, or absorbed through the skin.

Phthalimides are organic compounds that contain a phthalimide functional group. The phthalimide group consists of a pair of fused rings, a benzene ring and a five-membered ring containing two nitrogen atoms, with one of the nitrogen atoms being part of a carbonyl group.

Phthalimides are commonly used as intermediates in the synthesis of other organic compounds, including pharmaceuticals, agrochemicals, and dyes. They can also exhibit various biological activities, such as anti-inflammatory, antiviral, and anticancer properties. However, some phthalimides have been found to have toxic effects and may pose environmental and health concerns.

Indole-3-acetic acid (IAA) is not exactly a medical term, but rather a scientific term used in the field of biochemistry and physiology. It is a type of auxin, which is a plant hormone that regulates various growth and development processes in plants. IAA is the most abundant and best-studied natural auxin.

Medically, indole-3-acetic acid may be mentioned in the context of certain medical conditions or treatments related to plants or plant-derived substances. For example, some research has investigated the potential use of IAA in promoting wound healing in plants or in agricultural applications. However, it is not a substance that is typically used in medical treatment for humans or animals.

He discovered that 2,3,5-triiodobenzoic acid (TIBA) would speed up the flowering of soybeans. He also noted that in higher ... As a graduate student in 1943, Galston studied the use of 2,3,5-triiodobenzoic acid (TIBA) to encourage the flowering of ...
In research, 1-N-Naphthylphthalamic acid (NPA) and 2,3,5-triiodobenzoic acid (TIBA) are used as specific inhibitors of the ... 9-Hydroxyfluorene-9-carboxylic acid (HFCA), TIBA, and trans-cinnamic acid (TCA) are also example of Polar Auxin Transport ... As weak acids, the protonation state of auxins is dictated by the pH of the environment; a strongly acidic environment inhibits ... The mechanism below describes the process in which auxin is trapped in the cell by the so-called acid trap and how it can then ...
He discovered both that 2,3,5-triiodobenzoic acid (TIBA) would speed up the flowering of soybeans and that in higher ... These included 2,4-D, 2,4,5-T, MCPA (2-methyl-4-chlorophenoxyacetic acid, 1414B and 1414A, recoded LN-8 and LN-32), and ... The active ingredient of Agent Orange was an equal mixture of two phenoxy herbicides - 2,4-dichlorophenoxyacetic acid (2,4-D) ... The chemicals involved were 2,4-D, 2,4,5-T, and endothall (3,6-endoxohexahydrophthalic acid). During 1952-53, the unit ...
5-triiodobenzoic acid Chiba, Chiba, a Japanese city Chiba Prefecture, a Japanese prefecture TIBÁ, Tecnologia Intuitiva e Bio- ...
5-triiodobenzoic acid]. Die Naturwissenschaften (in German). 42 (4): 99. Bibcode:1955NW.....42Q..99D. doi:10.1007/BF00617249. ...
... triiodobenzoic acids MeSH D02.241.223.100.140.100.375.880.020 - acetrizoic acid MeSH D02.241.223.100.140.100.375.880.270 - ... quinic acid MeSH D02.241.511.852 - shikimic acid MeSH D02.241.511.902 - sugar acids MeSH D02.241.511.902.107 - ascorbic acid ... edetic acid MeSH D02.241.081.038.455 - egtazic acid MeSH D02.241.081.038.581 - iodoacetic acid MeSH D02.241.081.038.581.400 - ... hexuronic acids MeSH D02.241.081.844.915.400.500 - iduronic acid MeSH D02.241.081.901.177 - aconitic acid MeSH D02.241.081.901. ...
Triiodobenzoic Acids / chemistry Substances * Chlorides * Contrast Media * Triiodobenzoic Acids * Cesium * cesium chloride ...
Flowering in Fruit Trees and Annual Plants as Affected by Purines, Pyrimidines and Triiodobenzoic Acid. ... Flowering in Fruit Trees and Annual Plants as Affected by Purines, Pyrimidines and Triiodobenzoic Acid. ...
He discovered that 2,3,5-triiodobenzoic acid (TIBA) would speed up the flowering of soybeans. He also noted that in higher ... As a graduate student in 1943, Galston studied the use of 2,3,5-triiodobenzoic acid (TIBA) to encourage the flowering of ...
Triiodobenzoic Acids [D02.455.426.559.389.127.375.880]. *Iopamidol [D02.455.426.559.389.127.375.880.410] ...
ioglycamic acid (i′o-gli-kam′ik). 3,3′-[oxybis(methylene carbonylimino)]bis[2,4,6-triiodobenzoic acid];an ionic, water-soluble ... iodopanoic acid (i-o′do-pa-no′ik). SYN: iopanoic acid. iodophendylate (i-o′do-fen′dil-at). SYN: iophendylate. iodophilia (i-o′ ... iobenzamic acid (i-o-ben-zam′ik). A radiographic contrast medium formerly used for oral cholecystography. iocetamic acid (i′o- ... iodogorgoic acid (i-o′do-gor-go′ik). 3,5-Diiodotyrosine;a precursor of thyroxine. iodohippurate sodium (i-o′do-hip′poo-rat). A ...
5-triiodobenzoic acid. With the magnitude of hypertrophic growth from individual disks taken as a manifestation of putative ... naphthalene acetic acid (NAA, 0.54-5.37 μM)/indole acetic acid (IAA, 0.57-5.71 μM)/indole butyric acid (IBA, 0.49-4.9 μM)]. All ... Regeneration percentage was variable in response to BA level, and inclusion of α-naphthalene acetic acid (NAA) and gibberellic ... Media supplemented with naphthalene acetic acid as the sole growth regulator induced rhizogenesis in whole leaflets and leaflet ...
... serendipitously found to have an effect on sudden hearing loss and is the most commonly used derivative of triiodobenzoic acid. ... Gouveris H, Selivanova O, Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden ... Magnetic resonance imaging (MRI) with gadolinium diethylenetriamine-pentaacetic acid (DPTA) enhancement is the criterion ...
5-triiodobenzoic acid, led to fewer nematodes in the seeds. In addition, A. besseyi rarely migrated and multiplied in the ... Young panicles treated with 1-naphthaleneacetic acid produced more grains and nematodes, whereas plants treated with the auxin ...
Acids, Carbocyclic [D02.241.223] * Benzoates [D02.241.223.100] * Iodobenzoates [D02.241.223.100.400] * Triiodobenzoic Acids [ ... Triiodobenzoic Acids [D02.455.426.559.389.127.375.880] * Acetrizoic Acid [D02.455.426.559.389.127.375.880.020] ... Ioxaglic Acid, Calcium Salt (2:1) Narrower Concept UI. M0330187. Registry Number. 77131-63-6. Terms. Ioxaglic Acid, Calcium ... Triiodobenzoic Acids (1972-1986). Public MeSH Note. 87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM ...
Cell Nucleus Directed 2,3,5-triiodobenzoic Acid Conjugates. Journal: Medicinal Chemistry. Volume: 5 Issue: 4 Year: 2009 Page: ... Novel Cell Nucleus Directed Fluorescent Tetraazacyclododecane-Tetraacetic Acid Compounds. Journal: Medicinal Chemistry. Volume: ...
5-triiodobenzoic acid resulted in a reduction of haustorium formation induced by both host plants and the HIF 2,6-dimethoxy-ρ- ... Full-length amino acid sequences were aligned using MAFFT (v7.407) with the auto mode (Katoh and Standley, 2013). Alignment ... The auxin efflux inhibitor NPA and the influx inhibitor 3-chloro-4-hydroxyphenylacetic acid (CHPAA) were used to determine how ... Auxin, or indole-3-acetic acid (IAA), regulates various developmental processes throughout the plant body (Teale et al., 2006 ...
2,3,5-Triiodobenzoic acid. 88-82-4. More. 2-Methylacetophenone. 577-16-2. More. ...
Synonym: 3,3(Adipoyldiimino)bis(2,4,6-triiodobenzoic acid), Adipiodone. *. CAS Number 606-17-7 ...
NPA (naphthytphthalamic acid). · TIBA (2,3,5-triiodobenzoic acid). · Primarily used to alter auxin transport to elucidate mode ... acid, strigolactone, and jasmonic acid. Some do not elevate these to the status of one of the five classical hormones, so often ... ethylene and abscisic acid are both involved in defoliation of deciduous trees in the fall.. ... Classically, plants have been known to contain five hormones, which are auxin, cytokinin, gibberellic acid, ethylene and ...
Abscission and other responses induced by 2,3,5-triiodobenzoic acid in bean plants. Bot. Gaz. 1948. 109:447-73. DOI: 10.1086/ ... Foster A. S. The use of tannic acid and iron chloride for staining cell walls in meristematic tissue. Stain Technol. 1934. 9:91 ... Burton D. F. Anatomy of the cotton leaf and effects induced by 2,4-dichlorophenoxyacetic acid. Bot. Gaz. 1950. 111:325-31. DOI ... Murray Mary Aileen, Geraldine Whiting A. A comparison of the effectiveness of 2,4-dichlorophenoxyacetic acid and four of its ...
treelets, an IAA-transport inhibitor TIBA (tri-iodobenzoic acid) was applied around the trunk above the portion removal of ... Acid-Volatile Sulfide(AVS) has been shown to be the largest part of the activity of total sulfide content in anoxic sediments. ... Acid-Volatile Sulfide(AVS) controls the concentration of heavy metals in pore water of reduction phase sediments and it forms ... Focused on neutral phosphorus extractant (TBP, P205, P350, TRPO etc.)-diluent-water-acid system, this paper analyzes the ...
Recently it has been found that the growth-inhibiting chemical, TIBA (triiodobenzoic acid) slows down terminal growth and ... Amino acids in the seed oil are reported as: capric acid, 0.6; myristic, 1.7; X, 13.5; palmitic, 23.4; X, 10.4; stearic, 8.7; ... aspartic acid, 22.6; glutamic acid, 12.3; alanine, 6.0; glycine, 4.0; proline, 3.9; serine, 4.1. Toxicity. Unripe avocados are ... Experiments with gibberellic acid and cutting of both ends of the seed with a view to achieving more uniform germination have ...
6-triiodobenzoic acid) at room temperature yielding [Ln(H2O)8][DTA]3 in moderate (for the heavier lanthanoids) to good (for the ... We present a pathway to synthesize diatrizoate lanthanoid complexes directly from Ln2O3 and diatrizoic acid (DTAH = 3,5- ... Synthesis of lanthanoid complexes from Ln2O3 and diatrizoic acid. Australian Journal of Chemistry, 71 (12). pp. 939-944. ...
Most ICAs are derivatives of the triiodobenzoic acid, largely eliminated via urinary excretion without being metabolised, ... chelates of the trivalent gadolinium ion with polyaminocarboxylic acids. Chelation ensures that the toxic effects of the free ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
AMF could alleviate the effect of auxin-related inhibitors (2,3,5-triiodobenzoic acid, L-α-(Aminooxy)-ß-phenylpropionic acid ... Gas chromatography-mass spectrometry (GC-MS) was used to determine the levels of short-chain fatty acids (SCFAs) in rat gut. ... posing environmental risks in groundwater and discharging acid mine drainage, which contains large amounts of iron. In this ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
D2.455.526.510.286.500 Triiodobenzoic Acids D2.241.223.100.140.100.375.880 D2.241.223.100.400.880 D2.455.426.559.389.127. ... D10.251.400.143 Butyric Acid D2.241.81.160.140 D2.241.81.114.750 D10.251.400.241.140 D10.251.400.143.500 Caffeic Acids D2.241. ... B5.80.750.450 Keto Acids D2.241.607 D2.241.755 Ketoglutaric Acids D2.241.607.465 D2.241.755.465 L-Selectin D23.50.301.264. ... D2.705.675 Phosphoric Acid Esters D2.705.673 D2.705.400 (Replaced for 2012 by Organophosphates) Phosphorous Acids D2.705.676 ...
Ioxaglic Acid, Mannitol, Muscle, Smooth, Vascular, Triiodobenzoic Acids ... diatrizoate, ionic contrast medium, iopromide, iotrolan, ioxaglic acid, mannitol, meglumine diatrizoate plus sodium diatrizoate ...
Neither the inhibitors of ABC and auxin transporters, triiodobenzoic acid (TIBA), 1-N-naphythylphthalamic acid (NPA), verapamil ... The expression of ABCM10 (an ABCD transporter gene), TIR1_1 (an auxin receptor gene), and CAT4 (an amino acid transporter gene ...

No FAQ available that match "triiodobenzoic acids"